In another delay for the psychedelic treatment space, Compass Pathways announced adjusted timelines for two Phase III trials ...

The union says that hundreds attended the event, which protested the decline in animation employment in the L.A. area and ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Mineralys Therapeutics, Inc. ( (MLYS) ) has released its Q3 earnings. Here is a breakdown of the information Mineralys Therapeutics, Inc.

Cybersecurity, an area pivotal for companies implementing new technologies ... Creating an online account for a business that ...

Repligen posted solid growth and beat Wall Street's sales and adjusted earnings estimates.

Axsome Therapeutics surpassed revenue expectations in Q3, driven by strong sales from its key products.

Pivotal trial design can make or break a new therapy's commercial viability. This article explores how choosing the right ...

Syndax Pharmaceuticals (SNDX) stock dropped ~23% after the company posted Phase 2 trial data for its AML candidate, revumenib ...

Syndax Pharmaceuticals advances Revumenib for relapsed AML with FDA decision pending. See why SNDX stock is a key player in ...

In Germany, temporary employment — known as Arbeitnehmerüberlassung or Zeitarbeit — plays a pivotal role in the labor market. For U.S.